---
nav_exclude: true
title: "Interim Guidance: 4-Month Rifapentine-Moxifloxacin Regimen for the Treatment of Drug-Susceptible Pulmonary Tuberculosis - United States, 2022"
source_url: "https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=560384"
source_layer: us_cdc_mmwr
category: surveillance_summary
date: 2022-02-24
confidence: 中
mmwr_volume: ""
mmwr_issue: ""
---

## 摘要

This report describes a recommendation for using a 4-month regimen for the treatment of drug-susceptible pulmonary tuberculosis. 

## 詳細內容

This report describes a recommendation for using a 4-month regimen for the treatment of drug-susceptible pulmonary tuberculosis. 

## 關鍵發現

(需要透過 WebFetch 補充或人工審核來提取關鍵發現)

---
*萃取時間: 2026-02-05T15:12:47Z*
*資料來源: CDC MMWR*
